retatrutide pill form in Form: What UK Patients Need to Know – Bolt Pharmacy RETATRUTIDE: A Medication for Diabetes

In TRIUMPH-4, participants with obesity and knee osteoarthritis taking retatrutide 12 mg lost ~28.7% of body weight (~71 lbs at 68 weeks) and saw substantial improvements in pain and function: WOMAC pain scores reduced by 4.5 points (75.8%) Meaningful gains in physical function, with many patients essentially free of knee pain by study end If these results are confirmed in broader use, were not just talking about weight loss drugs anymorewere talking about disease-modifying therapies that simultaneously target obesity, pain, mobility, and downstream CV risk

Pharmaceuticals (Basel) 2022, 15(6)

Our design strategy was based on achieving a unimolecular molecule that was equipotent to CagriSema in vitro on GLP-1R and AMYRs

We need to work with insurance and health policy to establish criteria for qualifying for GLP-1RA and to advocate for people for whom other standard medications cannot substitute for GLP-1RA, the researcher went on to say